Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 5/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6264063 | 1.00 | CYP3A4 (0.41) | CYP3A4ACHEOPRK1OPRM1OPRD1 | |
| SCHEMBL14032468 | 1.00 | CYP3A4 (0.41) | CYP3A4ACHEOPRK1OPRM1OPRD1 | |
| SCHEMBL10608422 | 0.79 | SLC7A5 (0.50) | CYP3A4OPRK1OPRM1OPRD1 | |
| SCHEMBL296690 | 0.79 | SLC7A5 (0.50) | CYP3A4OPRK1OPRM1OPRD1 | |
| SCHEMBL23964694 | 0.79 | OPRM1 (0.43) | CYP3A4OPRM1 | |
| SCHEMBL38374 | 0.79 | SLC7A5 (0.50) | CYP3A4OPRK1OPRM1OPRD1 | |
| Bromide SCHEMBL10477399 | 0.78 | SLC7A5 (0.49) | CYP3A4OPRK1OPRM1OPRD1 | |
| Hydrochloric Acid SCHEMBL10477430 | 0.78 | SLC7A5 (0.49) | CYP3A4OPRK1OPRM1OPRD1 | |
| Hydrochloric Acid SCHEMBL10421601 | 0.78 | SLC7A5 (0.49) | CYP3A4OPRK1OPRM1OPRD1 | |
| Bromide SCHEMBL10477401 | 0.78 | SLC7A5 (0.49) | CYP3A4OPRK1OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795196-B2 | Mitochondria-targeting peptides | STEALTH BIOTHERAPEUTICS INC. (US) | 2023-10-24 | — | — | US | disclosed |
| US-20230146515-A1 | MITOCHONDRIA-TARGETING PEPTIDES | STEALTH BIOTHERAPEUTICS INC. | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795196-B2 | Mitochondria-targeting peptides | HSPE1, TFAM, TNNI3 | CYP3A4 4834/4885ACHE 4821/4885OPRK1 3460/4885 |
| US-20230146515-A1 | MITOCHONDRIA-TARGETING PEPTIDES | HSPE1, TFAM, TNNI3 | CYP3A4 4834/4885ACHE 4821/4885OPRK1 3460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.